500 mg/1,5 ml powder and solvent for injectable solution for im use
1 g/3 ml powder and solvent for injectable solution for im use
J01DD02 - Antibacterial for systemic use. Third Generation Cephalosporins
Panzid is indicated for the treatment of infections listed below in adults and in children including babies (from birth).
Bronchopulmonary infections in cystic fibrosis
Chronic suppurative media otitis
Outside malignant otitis
Complicated urinary tract infections
Complicated skin and soft tissue infections
Infections of the bones and joints
Peritonitis associated with dialysis in patients with continuous peritoneal dialysis (Continuous ambulatory peritoneal dialysis-CAPD).
Treatment of patients with bacteremia that occurs or is suspected to be associated with one of the infections listed above.
Ceftazidime can be used in the management of neutropenic patients with fever suspected to be caused by a bacterial infection.
Ceftazidime can be used in peri-operative prophylaxis of urinary tract infections of patients undergoing trans urethral resection of the prostate (TURP).
Magis Farmaceutici S.r.l.